Filtros de búsqueda

Lista de obras de Uwe Platzbecker

188Re anti-CD66 radioimmunotherapy combined with reduced-intensity conditioning and in-vivo T cell depletion in elderly patients undergoing allogeneic haematopoietic cell transplantation

artículo científico publicado en 2009

5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis

artículo científico publicado en 2009

72 PERSONALIZED TREATMENT APPROACH FOR GFI136N HETEROZYGOUS OR HOMOZYGOUS MDS PATIENTS

scholarly article by B. Lacramioara et al published April 2015 in Leukemia Research

A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy

artículo científico publicado en 2011

A novel complete blood count-based score to screen for myelodysplastic syndrome in cytopenic patients

artículo científico publicado en 2018

A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial

artículo científico publicado en 2010

A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes.

artículo científico publicado en 2017

A phase 3 randomized, placebo-controlled study assessing the efficacy and safety of epoetin-α in anemic patients with low-risk MDS

scientific article published on 30 March 2018

A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy

scientific article published on 19 June 2020

A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q

artículo científico publicado en 2011

A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome

scientific article published on 01 July 2019

Aberrant methylation of the M-type phospholipase A(2) receptor gene in leukemic cells

artículo científico publicado en 2012

Accuracy of physician assessment of treatment preferences and health status in elderly patients with higher-risk myelodysplastic syndromes.

artículo científico publicado en 2015

Accurate quantification of chromosomal lesions via short tandem repeat analysis using minimal amounts of DNA

artículo científico publicado en 2017

Activin Receptor II Ligand Traps and Their Therapeutic Potential in Myelodysplastic Syndromes with Ring Sideroblasts

artículo científico publicado en 2016

Activity of sirolimus in patients with myelodysplastic syndrome--results of a pilot study.

artículo científico publicado en 2005

Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignancies

artículo científico publicado en 2016

Acute heart failure after allogeneic blood stem cell transplantation due to massive myocardial infiltration by cytotoxic T cells of donor origin.

artículo científico publicado en 2001

Adoptive transfer of allogeneic regulatory T cells into patients with chronic graft-versus-host disease

artículo científico publicado en 2015

Allogeneic Hematopoietic Stem Cell Transplantation in a Rare Case of Tonsillar Mast Cell Sarcoma

scientific article published on 28 February 2020

Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT.

artículo científico publicado en 2016

Allogeneic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes and Prevention of Relapse

artículo científico publicado en 2020

Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study

artículo científico publicado en 2019

Allogeneic hematopoietic cell transplantation in patients age 60-70 years with de novo high-risk myelodysplastic syndrome or secondary acute myelogenous leukemia: comparison with patients lacking donors who received azacitidine

artículo científico publicado en 2012

Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndromes

artículo científico

Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

artículo científico publicado en 2017

Allogeneic stem cell transplantation in MDS: how? When?

artículo científico

Allogeneic stem cell transplantation mitigates the adverse prognostic impact of high diagnostic BAALC and MN1 expression in AML

scientific article published on 29 August 2020

Allogeneic stem-cell transplantation in patients with NPM1-mutated acute myeloid leukemia: results from a prospective donor versus no-donor analysis of patients after upfront HLA typing within the SAL-AML 2003 trial

artículo científico publicado en 2014

Allogeneic transplantation of CD34+ selected hematopoietic cells--clinical problems and current challenges

artículo científico publicado en 2004

Altered Structure and Function of Mesenchymal Stromal Cell-Derived Extracellular Matrix in MDS Can be Restored By Luspatercept

artículo científico publicado en 2019

Altered phenotype of natural killer cell subsets after haploidentical stem cell transplantation

artículo científico publicado en 2008

An optimized targeted Next-Generation Sequencing approach for sensitive detection of single nucleotide variants.

artículo científico publicado en 2018

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

artículo científico publicado en 2002

AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicity

artículo científico publicado en 2008

Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes?

artículo científico publicado en 2016

Association of Oesophageal Varices and Splanchnic Vein Thromboses in Patients with JAK2-Positive Myeloproliferative Neoplasms: Presentation of Two Cases and Data from a Retrospective Analysis

artículo científico publicado en 2013

Association with the single-nucleotide polymorphism (Glu785Lys) of the granulocyte colony-stimulating factor receptor with myelodysplastic syndromes and acute myeloid leukemia with multlineage dysplasia

artículo científico publicado en 2006

Associations of myeloid hematological diseases of the elderly with osteoporosis: A longitudinal analysis of routine health care data

scientific article published on 21 April 2018

Author Correction: Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signaling

artículo científico publicado en 2019

Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation

artículo científico publicado en 2013

Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial.

artículo científico publicado en 2011

Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group

artículo científico publicado en 2010

Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia

scholarly article by Michael Dickinson et al published 10 October 2018 in Blood

Azacytidine impairs NK cell activity in AML and MDS patients undergoing MRD-based pre-emptive treatment after allogeneic stem cell transplantation

artículo científico publicado en 2013

B-cell signaling in persistent polyclonal B lymphocytosis (PPBL).

artículo científico publicado en 2016

Beyond the Edge of Hypomethylating Agents: Novel Combination Strategies for Older Adults with Advanced MDS and AML.

artículo científico publicado en 2018

Biology-Driven Approaches to Prevent and Treat Relapse of Myeloid Neoplasia after Allogeneic Hematopoietic Stem Cell Transplantation

artículo científico publicado en 2019

Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry.

artículo científico publicado en 2016

CD34+-enriched peripheral blood progenitor cells from unrelated donors for allografting of adult patients: high risk of graft failure, infection and relapse despite donor lymphocyte add-back

artículo científico publicado en 2002

CRISPR/Cas9-edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC.

artículo científico publicado en 2017

Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia

artículo científico publicado en 2011

Case Report: Allogeneic Stem Cell Transplantation Following Induction With CPX-351 in Patients With Acute Myeloid Leukemia Is Feasible

artículo científico publicado en 2020

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide

artículo científico publicado en 2017

Chelerythrin activates caspase-8, downregulates FLIP long and short, and overcomes resistance to tumour necrosis factor-related apoptosis-inducing ligand in KG1a cells

artículo científico publicado en 2003

Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

artículo científico publicado en 2001

Clinical Challenges and Consequences of Measurable Residual Disease in Non-APL Acute Myeloid Leukemia

scientific article published on 23 October 2019

Clinical and functional implications of microRNA mutations in a cohort of 935 patients with myelodysplastic syndromes and acute myeloid leukemia

artículo científico publicado en 2014

Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patients

artículo científico publicado en 2017

Clinical, molecular, and immunological responses to pembrolizumab treatment of synchronous melanoma and acute myeloid leukemia

article

Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial.

artículo científico publicado en 2015

Clonal architecture of chronic myelomonocytic leukemias

artículo científico publicado en 2013

Clonal architecture of del(5q) myelodysplastic syndromes: aberrant CD5 or CD7 expression within the myeloid progenitor compartment defines a subset with high clonal burden

artículo científico publicado en 2015

Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2012

Combination of azacitidine and lenalidomide in myelodysplastic syndromes or acute myeloid leukemia-a wise liaison?

artículo científico publicado en 2013

Comment to the response to "severe pernicious anemia with distinct cytogenetic and flow cytometric aberrations mimicking myelodysplastic syndrome"

artículo científico publicado en 2012

Comparative molecular analysis of therapy-related and de novo acute promyelocytic leukemia.

artículo científico publicado en 2011

Comprehensive analysis of isolated der(1;7)(q10;p10) in a large international homogenous cohort of patients with myelodysplastic syndromes

scientific article published on 30 April 2019

Controversies on the Consequences of Iron Overload and Chelation in MDS

artículo científico publicado en 2020

Correction to: The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion

artículo científico publicado en 2020

Correction: Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients

scientific article published on 06 March 2020

Correlation of clinical response and response duration with miR-145 induction by lenalidomide in CD34(+) cells from patients with del(5q) myelodysplastic syndrome

artículo científico publicado en 2012

Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic stem cell transplantation

artículo científico publicado en 2002

Current and Future Treatment Options for Myelodysplastic Syndromes: More Than Hypomethylating Agents and Lenalidomide?

scientific article published on 01 December 2018

Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Gro

artículo científico publicado en 2015

Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of <i>TP53</i> mutations - a registry based analysis

artículo científico publicado en 2021

Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German

scientific article published on 24 September 2015

Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML

artículo científico publicado en 2022

Design and rationale of the QUAZAR Lower-Risk MDS (AZA-MDS-003) trial: a randomized phase 3 study of CC-486 (oral azacitidine) plus best supportive care vs placebo plus best supportive care in patients with IPSS lower-risk myelodysplastic syndromes a

Detection of relapse by sequential monitoring of chimerism in circulating CD34+ cells

artículo científico publicado en 2002

Determination of alpha-1 acid glycoprotein in patients with Ph+ chronic myeloid leukemia during the first 13 weeks of therapy with STI571.

artículo científico publicado en 2002

Development and validation of a model to predict platelet response to romiplostim in patients with lower-risk myelodysplastic syndromes

artículo científico publicado en 2014

Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNet

artículo científico publicado en 2018

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

artículo científico publicado en 2013

Disease management of patients with immune thrombocytopenia-results of a representative retrospective survey in Germany

artículo científico publicado en 2020

Disease-modifying activity of ruxolitinib in a patient with JAK2-negative CMML-2

artículo científico publicado en 2016

Do next-generation sequencing results drive diagnostic and therapeutic decisions in MDS?

Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?

artículo científico publicado en 2020

Donor cell leukemia: evidence for multiple preleukemic clones and parallel long term clonal evolution in donor and recipient

artículo científico publicado en 2017

Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial).

artículo científico publicado en 2017

Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients

artículo científico publicado en 2001

Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin

artículo científico publicado en 2000

Double lumen port access in patients receiving allogeneic blood stem cell transplantation

artículo científico publicado en 2001

Durable responses to ibrutinib in patients with relapsed CLL after allogeneic stem cell transplantation.

artículo científico publicado en 2016

ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation

artículo científico publicado en 2020

EZH2 mutations and impact on clinical outcome - an analysis in 1604 patients with newly diagnosed acute myeloid leukemia

scientific article published on 14 August 2019

Early Detection of Hepatitis E Virus Ribavirin Resistance Using Next-Generation Sequencing

scientific article published on 20 December 2019

Early allogeneic blood stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid leukemia

artículo científico publicado en 2001

Early intervention with allogeneic hematopoietic cell transplantation during chemotherapy-induced aplasia in patients with high-risk acute myeloid leukemia

artículo científico publicado en 2013

Effects of a home-based exercise program on physical capacity and fatigue in patients with low to intermediate risk myelodysplastic syndrome-a pilot study

artículo científico publicado en 2016

Effects of rigosertib on the osteo-hematopoietic niche in myelodysplastic syndromes

scientific article published on 16 July 2019

Efficacy and safety of deferasirox in non-thalassemic patients with elevated ferritin levels after allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2015

Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myeloma

scientific article published on 01 August 2006

Elevated AF1q expression is a poor prognostic marker for adult acute myeloid leukemia patients with normal cytogenetics

artículo científico publicado en 2009

Eltrombopag fails to improve severe thrombocytopenia in late-stage dyskeratosis congenita and diamond-blackfan-anaemia

artículo científico publicado en 2012

Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial.

artículo científico publicado en 2017

Enhanced labile plasma iron and outcome in acute myeloid leukaemia and myelodysplastic syndrome after allogeneic haemopoietic cell transplantation (ALLIVE): a prospective, multicentre, observational trial

scientific article published on 05 April 2018

Enhanced labile plasma iron in hematopoietic stem cell transplanted patients promotes Aspergillus outgrowth

scientific article published on 01 June 2019

Erythropoietin inhibits osteoblast function in myelodysplastic syndromes via the canonical Wnt pathway

artículo científico publicado en 2017

Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia

article published in 2018

Evaluation of six different types of sequential conditioning regimens for allogeneic stem cell transplantation in relapsed/refractory acute myelogenous leukemia - a study of the Acute Leukemia Working Party of the EBMT

artículo científico publicado en 2020

Evolution of NPM1-negative therapy-related myelodysplastic syndromes following curative treatment of NPM1-mutant AML

artículo científico publicado en 2017

Expression of FLIPLong and FLIPShort in bone marrow mononuclear and CD34+ cells in patients with myelodysplastic syndrome: correlation with apoptosis ⬇️

artículo científico publicado el 1 de diciembre de 2003

Fanconi anemia type C-deficient hematopoietic cells are resistant to TRAIL (TNF-related apoptosis-inducing ligand)-induced cleavage of pro-caspase-8.

artículo científico publicado en 2004

Feasibility of an exercise programme in elderly patients undergoing allogeneic stem cell transplantation - a pilot study

artículo científico publicado en 2015

Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.

artículo científico publicado en 2012

Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (≥60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMT

scientific article published on 23 October 2019

Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q.

artículo científico publicado en 2015

Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: Results from a German diagnostic study in comparison with an international control group

artículo científico publicado en 2015

From occasional date to civil union in APL

artículo científico publicado en 2017

Further evidence that paroxysmal nocturnal haemoglobinuria is a disorder of defective cell membrane lipid rafts

artículo científico publicado en 2015

GFI1(36N) as a therapeutic and prognostic marker for myelodysplastic syndrome

artículo científico publicado en 2016

Gemtuzumab ozogamicin as part of reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in patients with relapsed acute myeloid leukemia

artículo científico publicado en 2008

Genomic analysis of therapy-related acute promyelocytic leukemias arising after malignant and non-malignant disorders

artículo científico publicado en 2014

Graft clonogenicity and intensity of pre-treatment: factors affecting outcome of autologous peripheral hematopoietic cell transplantation in patients with acute myeloid leukemia in first remission

scientific article published on 01 December 2005

Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial

artículo científico publicado en 2009

Guideline-based indicators for adult patients with myelodysplastic syndromes

scientific article published on 01 August 2020

Haploidentical bone marrow transplantation with post-grafting cyclophosphamide: multicenter experience with an alternative salvage strategy

artículo científico publicado en 2011

Health care setting and severity, symptom burden, and complications in patients with Philadelphia-negative myeloproliferative neoplasms (MPN): a comparison between university hospitals, community hospitals, and office-based physicians.

artículo científico publicado en 2016

Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial

artículo científico publicado en 2014

High expression of the stem cell marker GPR56 at diagnosis identifies acute myeloid leukemia patients at higher relapse risk after allogeneic stem cell transplantation in context with the CD34+/CD38- population

scientific article published on 09 January 2020

High serum ferritin levels in newly diagnosed patients with myelodysplastic syndromes are associated with greater symptom severity

artículo científico publicado en 2020

How we manage adults with myelodysplastic syndrome

artículo científico publicado en 2019

Imatinib in Philadelphia chromosome-positive chronic phase CML patients: molecular and cytogenetic response rates and prediction of clinical outcome

artículo científico publicado en 2003

Imatinib in myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phase

artículo científico publicado en 2017

Imatinib mesylate does not impair the immunogenicity of human myeloid blood dendritic cells

artículo científico publicado en 2006

Imatinib mesylate selectively influences the cellular metabolism of cytarabine in BCR/ABL negative leukemia cell lines and normal CD34+ progenitor cells

artículo científico publicado en 2004

Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study

artículo científico publicado en 2020

Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity

artículo científico publicado en 2016

Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemia

artículo científico publicado en 2013

Impact of lenalidomide on the functional properties of human mesenchymal stromal cells

artículo científico publicado en 2012

Impact of pharmacokinetics on the toxicity and efficacy of clofarabine in patients with relapsed or refractory acute myeloid leukemia

artículo científico publicado en 2017

Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients

scientific article published on 13 July 2020

Impact of the revised International Prognostic Scoring System on the outcome of patients with acute myeloid leukemia with or without antecedent myelodysplastic syndrome

artículo científico publicado en 2013

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

artículo científico publicado en 2020

Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial.

artículo científico publicado en 2016

Increased EPO Levels Are Associated With Bone Loss in Mice Lacking PHD2 in EPO-Producing Cells

artículo científico publicado en 2016

Increased FGF-23 levels are linked to ineffective erythropoiesis and impaired bone mineralization in myelodysplastic syndromes

scientific article published on 06 August 2020

Increasing the effectiveness of hematopoiesis in myelodysplastic syndromes: erythropoiesis-stimulating agents and transforming growth factor-β superfamily inhibitors

artículo científico publicado en 2017

Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation

artículo científico publicado en 2017

Induction of Toll-like receptor 2 and 4 expression on CD4+ and CD8+ T cells in G-CSF-mobilized unrelated peripheral blood stem cell grafts during leukapheresis: impact on patient outcome

artículo científico publicado en 2007

Induction of short-term remission with single agent eltrombopag in refractory nucleophosmin-1-mutated acute myeloid leukemia

artículo científico publicado en 2014

Infectious complications in patients with myelodysplastic syndromes: A review of the literature with emphasis on patients treated with 5-azacitidine

artículo científico publicado en 2017

Influence of total genomic alteration and chromosomal fragmentation on response to a combination of azacitidine and lenalidomide in a cohort of patients with very high risk MDS.

artículo científico publicado en 2015

Infusion of bcr/abl peptide-reactive donor T cells to achieve molecular remission of chronic myeloid leukemia after CD34+ selected allogeneic hematopoietic cell transplantation

scientific article published on 31 August 2006

Integrating the "Immunome" in the Stratification of Myelodysplastic Syndromes and Future Clinical Trial Design

artículo científico publicado en 2020

Interactions of anemia, FGF-23 and bone in healthy adults - results from the Study of Health in Pomerania (SHIP)

artículo científico publicado en 2020

Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicine for acute myeloid leukemia in elderly patients

artículo científico publicado en 2018

Iron overload and its impact on outcome of patients with hematological diseases

artículo científico publicado en 2020

Iron overload in allogeneic hematopoietic cell transplantation outcome: a meta-analysis

artículo científico publicado en 2014

Is it already time for combination treatment in lower risk MDS?

scientific article published on 01 December 2012

Karyotype complexity and prognosis in acute myeloid leukemia

artículo científico publicado en 2016

Kinetics of CXCR-4 and adhesion molecule expression during autologous stem cell mobilisation with G-CSF plus AMD3100 in patients with multiple myeloma

artículo científico publicado en 2007

Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia

scientific article published on 20 December 2018

Lenalidomide as induction therapy before allogeneic stem cell transplantation in a patient with proliferative CMML-2 and del(5q) not involving the EGR1 locus

artículo científico publicado en 2007

Lenalidomide maintenance after allogeneic HSCT seems to trigger acute graft-versus-host disease in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia and del(5q): results of the LENAMAINT trial

artículo científico publicado en 2012

Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom).

artículo científico publicado en 2009

Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE Trial

artículo científico publicado en 2017

Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trial

artículo científico publicado en 2018

Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial

artículo científico publicado en 2019

Long-term survival benefit after allogeneic hematopoietic cell transplantation in chronic myelomonocytic leukemia

artículo científico publicado en 2020

Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomide

scientific article published on 30 September 2011

Loss of lenalidomide-induced megakaryocytic differentiation leads to therapy resistance in del(5q) myelodysplastic syndrome

scientific article published on 06 April 2020

Low frequency of calreticulin mutations in MDS patients

artículo científico publicado en 2014

Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase III study of the European Organisation fo

artículo científico publicado en 2011

Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study

artículo científico publicado en 2017

Luspatercept for the treatment of anemia in myelodysplastic syndromes and primary myelofibrosis

scientific article published on 02 January 2019

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

scientific article published on 01 January 2020

MRI-based liver iron content predicts for nonrelapse mortality in MDS and AML patients undergoing allogeneic stem cell transplantation

artículo científico publicado en 2012

Macroglossia as the only presenting feature of amyloidosis due to MGUS.

artículo científico publicado en 2013

Mammalian-target of rapamycin inhibition with temsirolimus in myelodysplastic syndromes (MDS) patients is associated with considerable toxicity: results of the temsirolimus pilot trial by the German MDS Study Group (D-MDS).

artículo científico publicado en 2016

Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet

scholarly article by Miguel A Sanz et al published 11 April 2019 in Blood

Management of patients with acute promyelocytic leukemia

scientific article published on 24 April 2018

Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial

artículo científico publicado en 2018

Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome

artículo científico publicado en 2015

Mesenchymal stem cells efficiently inhibit the proinflammatory properties of 6-sulfo LacNAc dendritic cells

artículo científico publicado en 2009

Mesenchymal stromal cells from patients with myelodyplastic syndrome display distinct functional alterations that are modulated by lenalidomide

artículo científico publicado en 2013

MiR-134-mediated β1 integrin expression and function in mesenchymal stem cells

artículo científico publicado en 2013

MiR144/451 Expression Is Repressed by RUNX1 During Megakaryopoiesis and Disturbed by RUNX1/ETO.

artículo científico publicado en 2016

MicroRNA-23a mediates post-transcriptional regulation of CXCL12 in bone marrow stromal cells

artículo científico publicado en 2014

Minimal residual disease-directed preemptive treatment with azacitidine in patients with NPM1-mutant acute myeloid leukemia and molecular relapse

artículo científico publicado en 2011

Mobilization of PML/RARalpha negative peripheral blood stem cells with a combination of G-CSF and CXCR4 blockade in relapsed acute promyelocytic leukemia pre-treated with arsenic trioxide

artículo científico publicado en 2009

Molecular cytogenetic monitoring from CD34+ peripheral blood cells in myelodysplastic syndromes: first results from a prospective multicenter German diagnostic study

artículo científico publicado en 2013

Momelotinib versus best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): a randomised, open-label, phase 3 trial

artículo científico publicado en 2017

Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation

artículo científico publicado en 2009

Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia

artículo científico publicado en 2020

Mutational hierarchies in myelodysplastic syndromes dynamically adapt and evolve upon therapy response and failure

artículo científico publicado en 2016

Myelodysplasia is in the niche: novel concepts and emerging therapies

artículo científico publicado en 2014

Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establish a transplantable stem cell niche disease unit.

artículo científico publicado en 2014

Myelodysplastic syndromes and bone loss in mice and men.

artículo científico publicado en 2017

Myelodysplastic syndromes with a deletion 5q display a characteristic immunophenotypic profile suitable for diagnostics and response monitoring

artículo científico publicado en 2014

Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

artículo científico publicado en 2020

Natural born survivors: the inglorious TP53

artículo científico publicado en 2020

New Approaches for Anemia in MDS

scientific article published on 01 September 2020

Old Dogs, New Tricks: Revisiting Immune Modulatory Approaches for Myelodysplastic Syndromes

artículo científico publicado en 2018

Optimizing management of myelodysplastic syndromes post-allogeneic transplantation

artículo científico publicado en 2011

Osteonecrosis of the jaw after osteoporosis therapy with denosumab following long-term bisphosphonate therapy

artículo científico publicado en 2013

Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide-an International Collaborative Study

artículo científico publicado en 2020

Outcome of patients treated for myelodysplastic syndromes with 5q deletion after failure of lenalidomide therapy.

artículo científico publicado en 2017

Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study

artículo científico publicado en 2014

Outcomes of Older Patients with NPM1 Mutated and FLT3-ITD Negative Acute Myeloid Leukemia Receiving Allogeneic Transplantation

artículo científico

P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate

artículo científico publicado en 2004

Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome

artículo científico publicado en 2012

Patient stratification in myelodysplastic syndromes: how a puzzle may become a map

artículo científico publicado en 2020

Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes

artículo científico publicado en 2017

Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial

artículo científico publicado en 2017

Personalized medicine in myelodysplastic syndromes: wishful thinking or already clinical reality?

artículo científico publicado en 2015

Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantation

artículo científico publicado en 2001

Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients.

artículo científico publicado en 2013

Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes

artículo científico publicado en 2019

Pitfalls in Assessing Response to Treatment in MDS

scientific article published on 01 September 2020

Platelet morphology, platelet mass, platelet count and prognosis in patients with myelodysplastic syndromes

artículo científico publicado en 2007

Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis

artículo científico publicado en 2016

Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes

artículo científico publicado en 2008

Pre-transplant weight loss predicts inferior outcome after allogeneic stem cell transplantation in patients with myelodysplastic syndrome

artículo científico publicado en 2015

Preference for involvement in treatment decisions and request for prognostic information in newly diagnosed patients with higher-risk myelodysplastic syndromes.

artículo científico publicado en 2014

Preparing Patients With Myelodysplastic Syndrome for Transplant When Is Pre-transplant Cytoreductive Therapy Appropriate?

artículo científico

Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS).

artículo científico publicado en 2016

Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes

artículo científico publicado en 2014

Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signals

artículo científico publicado en 2001

Prognostic Role of Gene Mutations in Chronic Myelomonocytic Leukemia Patients Treated With Hypomethylating Agents.

artículo científico publicado en 2018

Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2014

Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem-cell transplantation

artículo científico publicado en 2007

Prognostic impact of the ELN2017 risk classification in patients with AML receiving allogeneic transplantation

artículo científico publicado en 2020

Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT.

artículo científico publicado en 2016

Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study

artículo científico publicado en 2015

Prophylactic transfer of BCR-ABL-, PR1-, and WT1-reactive donor T cells after T cell-depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemia

artículo científico publicado en 2011

Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials

artículo científico publicado en 2018

Quantitative analyses of DAPK1 methylation in AML and MDS

artículo científico publicado en 2011

RNA-sequencing of acute promyelocytic leukemia primary blasts reveals novel molecular biomarkers of early death events

artículo científico publicado en 2020

RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates fasudil as an antileukemic drug

artículo científico publicado en 2015

Randomised, double-blind, placebo-controlled trial of oral budesonide for prophylaxis of acute intestinal graft-versus-host disease after allogeneic stem cell transplantation (PROGAST).

artículo científico publicado en 2014

Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents

artículo científico publicado en 2016

Randomized Phase III Trial of Retinoic Acid and Arsenic Trioxide Versus Retinoic Acid and Chemotherapy in Patients With Acute Promyelocytic Leukemia: Health-Related Quality-of-Life Outcomes

artículo científico publicado en 2014

Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group

artículo científico publicado en 2012

Real life experience with alemtuzumab treatment of patients with lower-risk MDS and a hypocellular bone marrow

artículo científico publicado en 2013

Recent advances in the treatment of lower-risk non-del(5q) myelodysplastic syndromes (MDS)

artículo científico publicado en 2016

Recent frustration and innovation in myelodysplastic syndrome

artículo científico publicado en 2016

Reconstitution of 6-sulfo LacNAc dendritic cells after allogeneic stem-cell transplantation

artículo científico publicado en 2012

Reconstitution of interleukin-17-producing T helper cells after allogeneic hematopoietic cell transplantation

artículo científico publicado en 2012

Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS)

artículo científico publicado en 2008

Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients

scientific article published on 29 January 2020

Reduced intensity conditioning allows for up-front allogeneic hematopoietic stem cell transplantation after cytoreductive induction therapy in newly-diagnosed high-risk acute myeloid leukemia

scientific article published on 01 April 2006

Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation in myeloid diseases

artículo científico publicado en 2003

Reduction of 5-azacitidine induced skin reactions in MDS patients with evening primrose oil.

artículo científico publicado en 2009

Relationship of different platelet response criteria and patient outcomes in a romiplostim myelodysplastic syndromes trial

artículo científico publicado en 2014

Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemia

artículo científico publicado en 2014

Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload

artículo científico publicado en 2012

Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5)

artículo científico publicado en 2015

Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia

artículo científico publicado en 2014

Retinoic acid and arsenic trioxide for acute promyelocytic leukemia

artículo científico publicado en 2013

Rhinocerebral zygomycosis and subsequent treatment decisions in a young patient with AML.

artículo científico publicado en 2009

Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial

artículo científico publicado en 2016

Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9

artículo científico publicado en 2016

Rps14, Csnk1a1 and miRNA145/miRNA146a deficiency cooperate in the clinical phenotype and activation of the innate immune system in the 5q- syndrome

scientific article published on 16 January 2019

SETBP1 mutation analysis in 944 patients with MDS and AML.

artículo científico publicado en 2013

SOS for veno-occlusive disease: defibrotide prophylaxis

artículo científico publicado en 2012

Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study

artículo científico publicado en 2020

Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial

artículo científico publicado en 2015

Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantation

artículo científico publicado en 2013

Second donation of granulocyte-colony-stimulating factor-mobilized peripheral blood progenitor cells: risk factors associated with a low yield of CD34+ cells

artículo científico publicado en 2005

Second donation of hematopoietic stem cells from unrelated donors for patients with relapse or graft failure after allogeneic transplantation

artículo científico publicado en 2008

Selective expansion of regulatory T cells during lenalidomide treatment of myelodysplastic syndrome with isolated deletion 5q.

artículo científico publicado en 2016

Sequential combination of azacitidine and lenalidomide in del(5q) higher-risk myelodysplastic syndromes or acute myeloid leukemia: a phase I study

artículo científico publicado en 2013

Setting Fire to ESA and EMA Resistance: New Targeted Treatment Options in Lower Risk Myelodysplastic Syndromes

artículo científico publicado en 2019

Severe chemotherapy-induced parosmia

artículo científico publicado en 2006

Severe pernicious anemia with distinct cytogenetic and flow cytometric aberrations mimicking myelodysplastic syndrome

artículo científico publicado en 2012

Siltuximab for Multicentric Castleman Disease-Letter

artículo científico publicado en 2015

Single agent talacotuzumab demonstrates limited efficacy but considerable toxicity in elderly high-risk MDS or AML patients failing hypomethylating agents

scientific article published on 03 December 2019

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

scientific article published on 18 June 2020

Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs

artículo científico publicado en 2001

Stem cell transplantation for patients with Evans syndrome

artículo científico publicado en 2009

Successful eradication of acquired factor-VIII-inhibitor using single low-dose rituximab

artículo científico publicado en 2009

Successful preemptive cidofovir treatment for CMV antigenemia after dose-reduced conditioning and allogeneic blood stem cell transplantation

artículo científico publicado en 2001

Successful treatment of molecular relapse in NPM1-positive AML using 5-azacytidine

artículo científico publicado en 2009

Suppression of RUNX1/ETO oncogenic activity by a small molecule inhibitor of tetramerization

artículo científico publicado en 2017

Survival, prognostic factors and rates of leukemic transformation in 381 untreated patients with MDS and del(5q): a multicenter study.

artículo científico publicado en 2012

TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation

artículo científico publicado en 2016

Targeting mycophenolate mofetil for graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation

artículo científico publicado en 2008

Telomere dynamics in patients with del (5q) MDS before and under treatment with lenalidomide

scientific article published on 21 September 2015

The Effect of Lenalidomide on Health-Related Quality of Life in Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes: Results From the MDS-005 Study

artículo científico publicado en 2017

The Evolving Landscape of Biomarkers for Anti-PD-1 or Anti-PD-L1 Therapy

artículo científico publicado en 2019

The IPSS-R has prognostic impact in untreated patients with MDS del(5q)

scientific article published on 23 July 2018

The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index

artículo científico publicado en 2020

The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes

artículo científico publicado en 2012

The graft content of donor T cells expressing gamma delta TCR+ and CD4+foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors

artículo científico publicado en 2007

The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML.

artículo científico publicado en 2013

The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion

scientific article published on 25 October 2019

The response to lenalidomide of myelodysplastic syndrome patients with deletion del(5q) can be sequentially monitored in CD34+ progenitor cells

artículo científico publicado en 2009

The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort

artículo científico publicado en 2018

The wolf of hypomethylating agent failure: what comes next?

artículo científico publicado en 2019

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS

artículo científico publicado en 2020

Therapy-related myeloid neoplasms following treatment with radioiodine

artículo científico publicado en 2011

Third-party mesenchymal stem cells as part of the management of graft-failure after haploidentical stem cell transplantation

artículo científico publicado en 2009

Time to improve health-related quality of life outcomes in patients with acute promyelocytic leukemia

artículo científico publicado en 2015

Tracking myeloid malignancies by targeted analysis of successive DNA methylation at neighboring CG dinucleotides

artículo científico publicado en 2019

Transcriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDS.

artículo científico publicado en 2010

Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signaling

scientific article published on 07 January 2019

Transplants in myelodysplastic syndromes

artículo científico

Treatment of MDS

artículo científico publicado en 2019

Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions--a retrospective multicenter analysis from the German Cooperative Transplant Study Gro

artículo científico publicado en 2014

Treatment of acute promyelocytic leukemia

Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab

artículo científico publicado en 2008

Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium

artículo científico publicado en 2008

Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

artículo científico publicado en 2017

Treatment of relapsing leukemia after allogeneic blood stem cell transplantation by using dose-reduced conditioning followed by donor blood stem cells and GM-CSF

scientific article published on 01 March 2001

Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple Myeloma

artículo científico publicado en 2011

Two cycles of risk-adapted consolidation therapy in patients with acute promyelocytic leukemia. Results from the SAL-AIDA2000 trial

artículo científico publicado en 2014

Update on developments in the diagnosis and prognostic evaluation of patients with myelodysplastic syndromes (MDS): consensus statements and report from an expert workshop

artículo científico

Use of Minimal Residual Disease in Acute Myeloid Leukemia Therapy

scientific article published on 30 January 2020

Use of targeted therapy for refractory ALK-positive anaplastic large cell lymphoma as a bridging strategy prior to allogeneic transplantation.

artículo científico publicado en 2012

Validation of a Molecular Risk Score for Prognosis of Patients With Acute Promyelocytic Leukemia Treated With All-trans Retinoic Acid and Chemotherapy-containing Regimens

artículo científico publicado en 2017

Validation of a post-hypomethylating agent failure prognostic model in myelodysplastic syndromes patients treated in a randomized controlled phase III trial of rigosertib vs. best supportive care

artículo científico publicado en 2017

Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control group

artículo científico publicado en 2014

Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents.

artículo científico publicado en 2017

Validation of the Revised Pretransplant Assessment of Mortality Score in Patients with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

artículo científico publicado en 2018

Validation of the revised international prognostic scoring system (IPSS-R) in patients with myelodysplastic syndrome: a multicenter study.

artículo científico publicado en 2013

WNT5A is induced by inflammatory mediators in bone marrow stromal cells and regulates cytokine and chemokine production

artículo científico publicado en 2012

When to transplant MDS, and what to do when transplant fails

artículo científico publicado en 2013

Who benefits from allogeneic transplantation for myelodysplastic syndromes?: new insights

artículo científico

Wnt5a is a key target for the pro-osteogenic effects of iron chelation on osteoblast progenitors

artículo científico publicado en 2016

Young Enough to Undergo Allogeneic Transplantation for Myelodysplastic Syndromes?: Considering the Results of the Medicare Coverage With Evidence Development Study

artículo científico publicado en 2019

[Successful treatment of acquired hemophilia A with recombinant porcine factor VIII]

artículo científico publicado en 2018

¹⁸F-FDG-PET/CT for detection of extramedullary acute myeloid leukemia

artículo científico publicado en 2011

γ-Glutamyl Transferase Is an Independent Biomarker of Splanchnic Thrombosis in Patients With Myeloproliferative Neoplasm

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda